Abstract:Alzheimer's disease is the most common neurodegenerative disease in the elderly. The pathogenesis of the disease is still unkown. β-amyloid (Aβ) has been demonstrated to involve the molecular mechanism of the disease. The aim of the present study is to investigate the toxic effect of the carboxyl-terminal peptide of β-amyloid precursor protein (APPC31) on Neuro2a cells as well as its role in the toxic process in Neuro2a cells induced by Aβ 42 in vitro. The plasmid vector and the APPC31 construct were transiently transfected into Neuro2a cells respectively by lipofectamine 2000. The viability of the cells was measured by the methyl thiazolyl tetrazolium (MTT) assay at 48 h after transfection, and their morphocytology was observed by 4,6-diamino-2-phenyl indole (DAPI) nucleus staining. Afterword different constructs including vector, WTAPP695, APP(D664A), the amino-terminal peptide of β-amyloid precursor protein (APPΔC31) and APPC31 were transiently transfected into Neuro2a cells respectively via the same method. At 24 h after transfection Aβ42 was added into the culture medium of Neuro2a cells with the desired concentration for another 24 h for cell studies. The viability and morphocytology of the cells were measured by using the MTT assay and DAPI nucleus staining, respectively. When incubated in the absence of Aβ42, the viability of cells transfected with vector and APPC31 construct were respective 0.81 ± 0.10 and 0.88 ± 0.12, and accordingly there was no significant difference between the these two groups (t = -0.78, P = 0.48); meanwhile no obvious cell nuclear morphological changes of apoptosis or death occurred. However when incubated in the presence of Aβ42, the viability of cells transfected with vector, WTAPP695, APP(D664A), APP–3C31 and APPC31 constructs were respective 0.82 ± 0.01, 0.78 ± 0.03, 0.55 ± 0.04, 0.81 ± 0.04, 0.78 ± 0.02 and 0.54 ± 0.02. The viability of cells transfected with WTAPP construct and APPC31 construct decreased significantly (F = 47.53, P<0.05) compared with the control group, meanwhile cells displayed condensed nuclear and even nuclear fragmentation. The overexpression of a certain level of APPC31 in Neuro2a cells failed to cause cell death, but this short peptide enhanced cytotoxicity induced by Aβ42 in Neuro2a cells. Thus, these results provided the experimental basis for the further explication of the pathogenesis of Alzheimer's disease.

Beta-Amyloid-Induced Neurotoxicity Of A Hybrid Septal Cell Line Associated With Increased Tau Phosphorylation And Expression Of Beta-Amyloid Precursor Protein

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

P3‐309: Overexpression of Hyperphosphorylated Tau Antagonizes Aβ‐potentiated Apoptosis with Preservation of Mitochondrial Elements

Endogenous Overproduction of Β-Amyloid Induces Tau Hyperphosphorylation and Decreases the Solubility of Tau in N2a Cells

Effects of Endogenous Β‐amyloid Overproduction on Tau Phosphorylation in Cell Culture

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

Tau Protein Antagonizes Cell Apoptosis Through Akt Pathway

Neuritogenic-Neurotoxic Effects of Membrane-Associated Forms ofAmyloid Precursor Prot ein

Overexpression Of Tau Proteins Antagonizes Amyloid-Beta-Potentiated Apoptosis Through Mitochondria-Caspase-3 Pathway In N2a Cells

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Aβ-mediated neurotoxicity: Microglia-mediated oxidative neurotoxicity

Changes In Mitochondrial Dynamics During Amyloid Beta-Induced Pc12 Cell Apoptosis

P2‐142: Toxic Effect of the Carboxyl‐terminal Peptide of Beta‐amyloid Precursor Protein (APPC31) on Neuro2a Cells

The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage

Antibody binding to cell surface amyloid precursor protein induces neuronal injury by deregulating the phosphorylation of focal adhesion signaling related proteins.

Mutations of beta-amyloid precursor protein alter the consequence of Alzheimer's disease pathogenesis.

Distinct brain pathologies associated with Alzheimer's disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis

Toxic Effect of Carboxyl-Terminal Peptide of Β-Amyloid Precursor Protein (APPC31) on Neuro2a Cells

Novel Cell Model for Tauopathy Induced by a Cell-Permeable Tau-Related Peptide

Amyloid-β Plaques Enhance Alzheimer's Brain Tau-Seeded Pathologies by Facilitating Neuritic Plaque Tau Aggregation

Protective Effects Of Erythropoietin On Tau Phosphorylation Induced By Beta-Amyloid

Beta Amyloid-Induced Upregulation of Death Receptor 6 Accelerates the Toxic Effect of N-terminal Fragment of Amyloid Precursor Protein.